US Equity Holdings

US Equity Holdings

US Equity Holdings is a hybrid operator-advisor platform conceived and run by serial entrepreneur Chester Aldridge. The firm licenses intellectual property, seeds companies, and recruits management teams across artificial intelligence, healthcare, renewable energy, basic materials, and entertainment. Its model is atypical: rather than drawing on a disclosed pool of LP commitments, Aldridge operates as a founder-CEO who channels his own balance sheet, his hands-on operating experience, and his advisory relationships into a portfolio that spans from early-stage biotech (Aelan Cell Technologies) to AI-driven defense platforms (DataShapes AI). The portfolio is built around a mix of direct incubations, strategic advisory roles, and IP commercialization projects. In healthcare, the footprint includes Credence MedSystems — a drug-delivery company that closed $39.9 million in new financing anchored by Novartis and Molex Ventures — as well as advisory posts with Prosetta Biosciences and Akonni Biosystems. In energy, Aldridge acts as Chief Advisor to Brillouin Energy, a low-energy-nuclear-reaction company backed by Tim Mellon and housed in a 37,000-square-foot Emeryville, California, facility, where an operating team is advancing a zero-emission heat source. The firm also touches defense AI through DataShapes AI, a radio-frequency-intelligence startup incubated with backing from Carl Berg’s venture firm. Geographically, the firm operates from the San Francisco Bay Area, with portfolio company operations in California, Maryland, and Hawaii, and past collaborations reaching Europe through Fraunhofer-Gesellschaft in Germany. Aldridge directs the platform alongside CFO Ben Zadik and Chief of Staff Tony Shapiro. The firm does not publish its total assets or deployment figures, but Aldridge states he has raised more than $300 million in early-stage private equity across multiple founder-led vehicles during his career. An operational milestone underscoring current scale was the $39.9 million funding round for Credence MedSystems, announced on the firm's website, representing a significant infusion from strategic pharmaceutical and venture partners. Outside its direct holdings, US Equity Holdings maintains a portfolio of advisory engagements, a music-management practice, and ownership in Hawaii-based luxury catamaran operator Sail Maui — pointing to a founder whose capital base is interwoven with a network of personal ventures. Where many family offices serve as pooled capital allocators, US Equity Holdings operates as an extension of its founder’s career. Aldridge does not deploy capital on behalf of a disclosed multi-generational fortune; he constructs companies, licenses the underlying technology, and retains strategic control — occasionally serving as a fractional CEO or board chair. This operator-heavy architecture gives the platform the feel of a personal holding company rather than a traditional single-family office, with the founder's reputation and track record acting as the primary currency for deal access and co-investor alignment.